Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price was up 29.7% during mid-day trading on Thursday . The stock traded as high as GBX 1,888 ($25.32) and last traded at GBX 1,801.01 ($24.15). Approximately 4,439,258 shares were traded during trading, an increase of 61% from the average daily volume of 2,754,210 shares. The stock had previously closed at GBX 1,389 ($18.63).
Johnson Matthey Price Performance
The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The company has a fifty day moving average of GBX 1,294.86 and a 200-day moving average of GBX 1,372.17. The firm has a market cap of £3.02 billion, a P/E ratio of 30.69, a P/E/G ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. On average, sell-side analysts anticipate that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Shareholders of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. The ex-dividend date of this dividend was Thursday, April 10th. This represents a dividend yield of 1.88%. This is a boost from Johnson Matthey's previous dividend of $22.00. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Activity
In related news, insider Liam Condon acquired 27 shares of the stock in a transaction on Wednesday, March 19th. The shares were acquired at an average price of GBX 1,445 ($19.38) per share, with a total value of £390.15 ($523.20). 0.61% of the stock is currently owned by corporate insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
